PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 1, 1969Circulation131 citationsOpen Access

The Value of Aggressive Therapy in the Hypertensive Patient with Azotemia

View Full Paper
WMWilliam J. MroczekMDMichael DavidovLGLillian Gavrilovich

Key Result

Intravenous diazoxide and oral furosemide in hypertensive patients with azotemia initially increased BUN and creatinine, but long-term therapy reduced BUN by 24 mg/dL and creatinine by 2.8 mg/dL.

Key Points

  • To evaluate the impact of aggressive therapy on diastolic blood pressure and renal function in hypertensive patients with azotemia.
  • Administered diazoxide intravenously and furosemide orally to 25 hypertensive patients with azotemia.
  • Monitored blood pressure and urinary output over a 2-week treatment period.
  • Conducted follow-up assessments on patient outcomes and kidney function at three months and beyond.
  • During treatment, average mean arterial pressure decreased by 40%, improving cardiovascular status.
  • Initial increases in BUN (19%) and serum creatinine (17%) were observed; however, reductions were noted at three months.
  • By month 26, 16 patients had stabilized with average BUN at 22 mg/100 ml and serum creatinine at 1.8 mg/100 ml.

Study Design

Type

Observational (n=25)

Structured PICO

Does aggressive therapy with intravenous diazoxide and oral furosemide improve cardiovascular and renal outcomes in hypertensive patients with azotemia?

P
Population
25 hypertensive patients with azotemia
I
Intervention
Intravenous diazoxide and oral furosemide targeted to keep diastolic blood pressure under 110 mm Hg and urinary output over 1 L/day
O
Outcome
Changes in mean arterial pressure, blood urea nitrogen (BUN), and serum creatininesurrogate

Aggressive blood pressure lowering with diazoxide and furosemide in hypertensive patients with azotemia may cause transient worsening of renal function but is associated with long-term improvements in cardiovascular status and renal parameters in survivors.

Abstract

By giving diazoxide intravenously and furosemide orally the diastolic blood pressure was kept under 110 mm Hg and the urinary output over 1 L/day for a 2-week period in 25 hypertensive patients with azotemia. During the first 2 weeks of treatment three patients died. Although the 40% decrease in mean arterial pressure in the remaining patients was associated with immediate improvement in the cardiovascular status, for example, clearing of congestive heart failure and papilledema, there was a 19% average increase in BUN and 17% average increase in serum creatinine values. Three months later, however, maintenance of the reduced arterial pressure was associated with average reductions of 24 mg/100 ml in BUN and of 2.8 mg/100 ml in serum creatinine below control values. Each of the patients who remained on therapy continued to do well. Twenty-six months later six additional patients had died. In the remaining 16 patients the average mean arterial pressure was 117 mm Hg; papilledema had cleared; the average concentration of BUN was 22 mg/100 ml; the average serum creatinine was 1.8 mg/100 ml.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mroczek et al. (1969) conducted an observational in Hypertensive patients with azotemia (n=25). Intravenous diazoxide and oral furosemide was evaluated on Blood pressure, renal function, and mortality. Intravenous diazoxide and oral furosemide in hypertensive patients with azotemia initially increased BUN and creatinine, but long-term therapy reduced BUN by 24 mg/dL and creatinine by 2.8 mg/dL.

synapsesocial.com/papers/6a09834830285ee4a1340651https://doi.org/10.1161/01.cir.40.6.893
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Effect of Oral Diazoxide on Hypertension and Sodium Excretion in Chronic Renal Failure1973 · 2 citations
  2. 2Acute Treatment of Hypertension With Slow Infusion of Diazoxide1983 · 19 citations
  3. 3Diazoxide and renal function in man1971 · 34 citations
  4. 4Clinical Evaluation of Diazoxide1963 · 85 citations
  5. 5Use of Diazoxide in Hypertension with Renal Failure1971 · 72 citations